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A Lewis-acid promoted one-carbon homologation of an aspartic acid semialdehyde with trimethylsi-
lyldiazomethane has led to the efﬁcient synthesis of two silicon-containing a-amino acids. The use of
trimethylaluminium or catalytic tin(II) chloride gave novel 4-oxo-5-trimethylsilanyl derived amino acids
in yields of 71e88%. An investigation into the reactivity of these highly functional a-amino acids showed
that selective cleavage of the CeSi bond could be achieved under mild basic conditions to give a pro-
tected derivative of the naturally occurring amino acid, 4-oxo-L-norvaline. Alternatively, Peterson oleﬁ-
nation with aryl or alkyl aldehydes resulted in the formation of E-enone derived a-amino acids.
 2014 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/3.0/).Fig. 1. Silicon-containing a-amino acids and peptides.1. Introduction
a-Amino acids are the structural building blocks of life, serving
as the key components of all proteins and enzymes.1 They also
play an important role in many enzymatic reactions and in signal
induction pathways. This importance in combination with the
rapid and continual advances in the biomedical sciences has re-
quired the development of novel approaches to optically active a-
amino acids and in particular functional, non-proteinogenic ana-
logues.2 As well as being used to probe the mechanism of en-
zymes and study the bioactive conformations of peptides and
proteins, these compounds often have signiﬁcant pharmacological
properties.
In this regard, unnatural silicon-containing a-amino acids and
peptides have found many applications in structural biology and
medicinal chemistry.3 The inclusion of a silicon-containing group
has been shown to improve lipophilicity, while silicon analogues of
proteinogenic a-amino acids such as b-trimethylsilyl alanine (1)4
and g-(dimethylsila)proline (2)5 have demonstrated increased re-
sistance to proteolytic degradation and increased cellular uptake,
respectively (Fig. 1). A number of silicon-containing bio-isosteres
with enhanced stability have been utilised for the development of
therapeutically active peptides.3 For example, a disilanol analogue
of phenylalanine has been used as a transition-state-like hydratedx: þ44 141 330 4888; e-mail
rland).
r Ltd. This is an open access articlcarbonyl for the generation of a highly potent angiotensin-
converting enzyme inhibitor 3.6
Despite their enhanced stability and advantageous pharmaco-
logical properties, synthetic routes towards silicon-containing
amino acids are still relatively limited in number.3,7 Noteworthy
approaches include the use of a reverse aza-Brook rearrangement
of allyl and furyl N-trialkylsilyl amines for the synthesis of a-tri-
alkylsilyl a-amino acids.8 More recently, Cavelier and co-workers
prepared g-silylated a-amino acids by a platinum-catalysed
hydrosilylation of unsaturated precursors,7b while Ramesh and
Reddy used a zinc mediated allylation of a chlorosilane as the keye under the CC BY license (http://creativecommons.org/licenses/by/3.0/).
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derivative 4 (Fig. 1).7h
During a recent study into the synthesis of a-amino acids
bearing ketone side-chains, we unexpectedly formed stable 4-oxo-
5-trimethylsilanyl compounds derived from L-aspartic acid. Fol-
lowing further investigation of this serendipitous result, we now
report the highly efﬁcient synthesis of these compounds by the
one-carbon homologation of N-Boc-protected aspartic acid semi-
aldehydes with trimethylsilyldiazomethane in the presence of
a Lewis acid. We also describe a preliminary study of the reactivity
of these compounds with a novel synthesis of a 4-oxo-L-norvaline
derivative, and the preparation of E-enone derived a-amino acids
via Peterson oleﬁnation.
2. Results and discussion
As outlined in Scheme 1, our proposed approach to 4-oxo-5-
trimethylsilanyl derived a-amino acids involved the rapid and ef-
ﬁcient protection of L-aspartic acid (5) using a protecting group
strategy that would allow the selective reduction of the b-carbonyl
moiety. The resulting aspartic acid semialdehyde would then be
used to investigate the formation of the target oxotrialkylsilane by
a one-carbon homologation reaction with trimethylsilyldiazo-
methane. Once this step had been optimised, it was proposed that
these types of compounds could be used as building blocks for the
preparation of more elaborate side-chains.Scheme 1. Proposed approach to 4-oxo-5-trimethylsilanyl derived a-amino acids from
L-aspartic acid (5).It was decided to use di-Boc aspartic acid semialdehyde 8, the
synthesis of which was ﬁrst reported by Martín and co-workers9a
and has been used by others for the preparation of a range of un-
natural a-amino acids.9 N,N0-Di-tert-butoxycarbonyl L-aspartic acid
dimethyl ester (7) was initially prepared in two steps from L-
aspartic acid (5) (Scheme 2). A one-pot esteriﬁcation and mono-N-
Boc protection was followed by further reaction with di-tert-butyl
dicarbonate and a catalytic amount of DMAP, which gave 7 inScheme 2. Four-step synthesis of 4-oxo-5-trimethylsilanyl derived a-amino acid 9.quantitative yield. Using the steric bulk of the bis-protected amine,
regioselective reduction of the b-methyl ester was then achieved
using DIBAL-H. This allowed the isolation of aspartic acid semi-
aldehyde 8 in 87% yield.
With semialdehyde 8 in hand, methods for conversion to the
corresponding 4-oxo-5-trimethylsilanyl derivative 9 were next in-
vestigated. In 1987, Aoyama and Shioiri demonstrated that 2-
oxotrialkylsilanes could be formed from the reaction of aldehydes
with trimethylsilyldiazomethane in the presence of magnesium
bromide.10 More recently, Lee and co-workers reported a similar
reaction using catalytic indium(III) chloride (2mol %) that gave high
yields of 2-trimethylsilyl ketones.11 In these transformations, the
Lewis acid-activated aldehyde is subjected to nucleophilic attack by
trimethysilyldiazomethane. The resulting intermediate then un-
dergoes a 1,2-hydride shift with simultaneous extrusion of nitrogen
and formation of the 2-oxotrialkylsilane. In both of these studies,
quenching the reaction with dilute acid or puriﬁcation by silica gel
ﬂash chromatography was avoided to prevent protodesilylation
and formation of the corresponding methyl ketones.12 Using the
Aoyama procedure with semialdehyde 8, trimethylsilyldiazo-
methane and a stoichiometric amount of magnesium bromide
returned mainly starting material. However, the use of a stronger
Lewis acid such as trimethylaluminium13 allowed clean conversion
to 4-oxo-5-trimethylsilane 9 (Scheme 2). Surprisingly, 9 was found
to be stable to protodesilylation. Work-up of this reaction with an
acid wash (0.1 M HCl) and puriﬁcation by silica gel ﬂash chroma-
tography gave 4-oxo-5-trimethylsilane 9 in 71% yield. A less pyro-
phoric Lewis acid was then investigated and the use of catalytic
tin(II) chloride14 (5 mol %) resulted in the isolation of 4-oxo-5-
trimethylsilane 9 in an optimal yield of 85%.
While the synthesis of 4-oxo-5-trimethylsilane 9 was success-
fully achieved, we were concerned that subsequent reactions with
this intermediate may be limited. Di-N-Boc-protected a-amino
esters are known to racemise more easily under basic conditions
due to the acidic nature of the a-hydrogen.15 Furthermore, the
steric bulk associated with the two N-Boc groups of a-amino acid
derivatives can hinder reactions of the side-chain.9g,16 Therefore,
a mono-N-Boc-protected analogue of 9 was prepared (Scheme 3).
Selective removal of one of the Boc protecting groups from aspartic
acid semialdehyde 8was achieved using lithium bromide under the
conditions reported byMartín and co-workers.17 This generated the
mono-N-Boc-protected analogue 10 in 92% yield. Reaction of 10
with trimethylsilyldiazomethane and tin(II) chloride (5 mol %) gave
4-oxo-5-trimethylsilane 11 in an excellent 88% yield. Like di-N-Boc
analogue 9, 4-oxo-5-trimethylsilane 11was isolated using an acidic
work-up (0.1 M HCl) and puriﬁed by silica gel ﬂashScheme 3. Synthesis of 4-oxo-5-trimethylsilane 11 and conversion to 4-oxo-L-norva-
line derivative 13.
Scheme 4. Synthesis of E-enone derived a-amino acids 18e20 via Peterson oleﬁnation
of 4-oxo-5-trimethylsilane 11.
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oxo-5-trimethylsilane 9 was reasoned due to the substantial steric
bulk associated with the two Boc protecting groups. However, the
facile and high yielding synthesis of mono-N-Boc-protected 4-oxo-
5-trimethylsilane 11 shows that unhindered oxotrialkylsilanes of
this type are stable enough to be isolated.18
Having prepared 4-oxo-5-trimethylsilanyl derived amino acid
11, we were interested in examining the reactivity of this com-
pound for the synthesis of biologically and synthetically useful a-
amino acids. The ﬁrst target was 4-oxo-L-norvaline, a rare ketone-
substituted a-amino acid produced as a metabolite from orni-
thine by Clostridium sticklandii and in bone marrow by a-amino-
levulinic acid synthetase.19 The biological importance of this a-
amino acid has resulted in a number of syntheses,13b,20 as well as an
investigation into its use as an inhibitor of oligosaccharyltransfer-
ase.20f It was proposed that protodesilylation of 4-oxo-5-
trimethylsilane 11 would result in a short synthesis of 4-oxo-L-
norvaline derivatives (Scheme 3). While protodesilylation is nor-
mally performed under acidic conditions,10 we wanted to maintain
the N-Boc protecting group. Therefore, initial attempts at cleavage
of the CeSi bond were conducted under basic conditions. Treat-
ment of 4-oxo-5-trimethylsilane 11 with TBAF led to complete
decomposition. However, selective removal of the trimethylsilyl
group in the presence of the methyl ester was efﬁciently achieved
with 5% potassium hydroxide, which gave 4-oxo-L-norvaline de-
rivative 12 in 92% yield. The two-step, one-carbon homologation
converting semialdehyde 10 to methyl ketone 12 represents
a simple and highly efﬁcient alternative to standard multi-step
protocols.10 Hydrolysis of 12 using caesium carbonate then gave
N-Boc-protected 4-oxo-L-norvaline 13 in 94% yield. This is a form of
4-oxo-L-norvaline that is used for peptide synthesis20f and the ap-
proach described here allows a seven-step preparation in 61%
overall yield.
A study has also been performed to evaluate the use of 4-oxo-5-
trimethylsilane 11 as a substrate in the Peterson oleﬁnation for the
synthesis of E-enone derived a-amino acids. a-Amino acids bearing
an enone side-chain have many applications.21 These include their
use in 6-endo- or 6-exo-trig cyclisations for the stereoselective
synthesis of highly substituted pipecolic acids.22 Initial attempts at
Peterson oleﬁnation of 4-oxo-5-trimethylsilane 11 with benzalde-
hyde using either lithium diisopropylamide (LDA) or lithium
bis(trimethylsilyl)amide (LiHMDS) led to only substantial de-
composition of 11. After careful experimentation, it was found that
the order of reagent addition was crucial for success. In situ for-
mation of LDA and dropwise addition via cannula to a THF solution
of 4-oxo-5-trimethylsilane 11 at78 C, followed by the addition of
benzaldehyde gave E-enone 14 in 48% yield (Scheme 4). At this
stage, the enantiopurity of enone 14 was determined to check that
the integrity of the stereocentre had been retained during the stages
of the synthetic route where di-N-Boc compounds has been gen-
erated and through the use of LDA. A comparison of (2S)-14 and
racemic-14 (prepared from D/L-aspartic acid) using chiral HPLC
showed the enantiomeric excess of (2S)-14 was >99% ee, conﬁrm-
ing that no racemisation had taken place during the synthetic
route.23 Following this result, the scope of the Peterson reactionwas
extended to two further analogues. Reaction of 11 with 4-
bromobenzaldehyde and hydrocinnamaldehyde gave the corre-
sponding enones 15 and 16 in comparable yields. NMR spectroscopy
of the crude material from the Peterson reactions showed only the
presence of the E-isomer, demonstrating a highly selective process.
Methods for the deprotection of enones 14e16 were then in-
vestigated. For example, a one-step procedure was demonstrated
for removal of both the Boc protecting group and hydrolysis of the
methyl ester of enone 14 using 6 M HCl under reﬂux conditions
(Scheme 4). Following recrystallisation, amino acid 17 was isolated
in 62% yield. However, a more efﬁcient approachwas possible usinga stepwise deprotection approach. Hydrolysis of the ester using
caesium carbonate, followed by TFA-mediated removal of the Boc
group under mild conditions gave after recrystallisation, enone
derived a-amino acids 18e20 in 93e98% yield over the two steps.
This approach also has the advantage of generating the N-Boc-
protected a-amino acids after the ﬁrst step, which could have direct
application in peptide synthesis.3. Conclusions
In summary, two novel 4-oxo-5-trimethylsilanyl derived a-
amino acids have been prepared by the reaction of aspartic acid
semialdehydes with trimethylsilyldiazomethane in the presence of
Lewis acids. In particular, the use of catalytic tin(II) chloride allowed
the synthesis of these compounds in excellent yields. Unlike simi-
lar 2-oxo-trimethylsilanes, these compounds were found to be
relatively stable to protodesilylation and could be isolated using
a dilute acid work-up and puriﬁed by silica gel ﬂash column chro-
matography. Based on this relative stability, preliminary studies
into the synthetic utility of these compounds have been conducted.
Selective cleavage of the CeSi bond of 4-oxo-5-trimethylsilane 11
was achieved under mild basic conditions generating derivatives of
the non-proteinogenic a-amino acid, 4-oxo-L-norvaline. Alterna-
tively, Peterson oleﬁnation of 11 with LDA and various aldehydes
led to the preparation of E-enones as the sole products in good
yields. Work to investigate further synthetic and biological appli-
cations of the 4-oxo-5-trimethylsilanyl derived a-amino acids
generated from this study, including their use as structural ana-
logues in therapeutic peptides, is currently underway.4. Experimental section
4.1. General methods
All reagents and starting materials were obtained from com-
mercial sources and used as received. All dry solvents were puriﬁed
using a PureSolv 500 MD solvent puriﬁcation system. All reactions
were performed under an atmosphere of argon unless otherwise
mentioned. Brine refers to a saturated solution of sodium chloride.
Flash column chromatography was carried out using Fisher matrix
silica 60. Macherey-Nagel aluminium-backed plates pre-coated
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and were visualised by staining with KMnO4. 1H NMR and 13C NMR
spectra were recorded on a Bruker DPX 400 spectrometer with
chemical shift values in parts per million (ppm) relative to TMS (dH
0.00 and dC 0.0) or residual chloroform (dH 7.28 and dC 77.2) as
standard. Proton and carbon assignments are based on two-
dimensional COSY and DEPT experiments, respectively. Mass
spectra were obtained using a JEOL JMS-700 spectrometer. Infrared
spectra were obtained neat using a Shimadzu IRPrestige-21 spec-
trometer. Melting points were determined on a Reichert platform
melting point apparatus. Optical rotations were determined as
solutions irradiating with the sodium D line (l¼589 nm) using
an Autopol V polarimeter. [a]D values are given in units
101 deg cm2 g1.4.2. Dimethyl (2S)-2-(tert-butoxycarbonylamino)butane-1,4-
dioate (6)9a
Chlorotrimethylsilane (21.2 mL, 165.4 mmol) was added slowly
to a stirred suspension of L-aspartic acid (5) (5.00 g, 37.6 mmol) in
methanol (100 mL) at 0 C. The reaction mixture was allowed to
stir for 1 h at 0 C and then at room temperature for 24 h. Trie-
thylamine (34.0 mL, 244.4 mmol) and di-tert-butyl dicarbonate
(9.02 g, 41.4 mmol) were added slowly and the mixture stirred for
2 h. The reaction mixture was concentrated in vacuo and the
resulting residue dissolved in diethyl ether (200 mL) and ﬁltered
to remove the white precipitate. The ﬁltrate was concentrated in
vacuo and puriﬁed using ﬂash column chromatography (35% ethyl
acetate in petroleum ether) to yield dimethyl (2S)-2-(tert-butox-
ycarbonylamino)butane-1,4-dioate (6) as a white solid (9.81 g,
100%). Mp 58e60 C; nmax (NaCl) 3406 (NH), 2927 (CH), 2360,
1704 (C]O), 1458, 1159, 1045 cm1; [a]D25 þ35.8 (c 1.0, CHCl3),
lit.9a [a]D25 þ30.8 (c 2.1, CHCl3); dH (400 MHz, CDCl3) 1.47 (9H, s,
tBu), 2.85 (1H, dd, J 16.8, 4.2 Hz, 3-HH), 3.03 (1H, dd, J 16.8, 4.2 Hz,
3-HH), 3.72 (3H, s, OMe), 3.78 (3H, s, OMe), 4.58e4.61 (1H, m, 2-
H), 5.50 (1H, br d, J 8.4 Hz, NH); dC (101 MHz, CDCl3) 28.3 (3CH3),
36.7 (CH2), 49.9 (CH), 52.1 (CH3), 52.8 (CH3), 80.2 (C), 155.4 (C),
171.5 (C), 171.6 (C); m/z (CI) 262 (MHþ, 15%), 206 (100), 162 (36),
85 (13); HRMS (CI): MHþ, found 262.1293. C11H20NO6 requires
262.1291.4.3. Dimethyl (2S)-2-(di-tert-butoxycarbonylamino)butane-
1,4-dioate (7)9a
Dimethyl (2S)-2-(tert-butoxycarbonylamino)butane-1,4-
dioate (0.90 g, 3.50 mmol) (6) was dissolved in acetonitrile
(50 mL). 4-Dimethylaminopyridine (0.08 g, 0.70 mmol) and di-
tert-butyl dicarbonate (0.80 g, 3.80 mmol) were added and the
reaction mixture was allowed to stir at room temperature for 3 h.
A further quantity of di-tert-butyl dicarbonate (0.40 g,
1.90 mmol) was added and the mixture was allowed to stir at
room temperature for 24 h. The solvent was removed in vacuo
and the crude product was puriﬁed using ﬂash column chroma-
tography (20% ethyl acetate in petroleum ether) to yield dimethyl
(2S)-2-(di-tert-butoxycarbonylamino)butane-1,4-dioate (7) as
a white solid (1.25 g, 100%). Mp 55e57 C; nmax (NaCl) 2857 (CH),
1747 (C]O), 1458, 1375, 1145 cm1; [a]D25 61.5 (c 2.0, CHCl3),
lit.9a [a]D25 61.0 (c 2.0, CHCl3); dH (400 MHz, CDCl3) 1.53 (18H, s,
2tBu), 2.77 (1H, dd, J 16.4, 6.4 Hz, 3-HH), 3.29 (1H, dd, J 16.4,
7.2 Hz, 3-HH), 3.73 (3H, s, OMe), 3.76 (3H, s, OMe), 5.48 (1H, dd, J
7.2, 6.4 Hz, 2-H); dC (101 MHz, CDCl3) 28.0 (6CH3), 35.7 (CH2),
52.0 (CH3), 52.6 (CH3), 54.9 (CH), 83.6 (2C), 151.6 (2C), 170.3
(C), 171.1 (C); m/z (CI) 362 (MHþ, 6%), 306 (38), 250 (33), 206
(100), 162 (50); HRMS (CI): MHþ, found 362.1819. C16H28NO8
requires 362.1815.4.4. Methyl (2S)-2-(di-tert-butoxycarbonylamino)-4-
oxobutanoate (8)9a
Dimethyl (2S)-2-(di-tert-butoxycarbonylamino)butane-1,4-
dioate (7) (6.90 g, 19.1 mmol) was dissolved in diethyl ether
(150 mL) and cooled to 78 C. DIBAL-H (26.8 mL, 26.8 mmol) was
added dropwise and the solution was allowed to stir at 78 C for
24 h. A saturated solution of ammonium chloride was added
(40 mL) and the reaction mixture was allowed to warm to room
temperature. It was ﬁltered through a pad of Celite with diethyl
ether (300 mL) and concentrated in vacuo. Following puriﬁcation
by column chromatography (10% ethyl acetate in petroleum ether),
methyl (2S)-2-(di-tert-butoxycarbonylamino)-4-oxobutanoate (8)
was obtained as a colourless oil (5.50 g, 87%). nmax (NaCl) 3132, 2796
(CH), 1782 (C]O), 1678, 1199, 1072 cm1; [a]D26 49.2 (c 3.4, CHCl3),
lit.9a [a]D25 54.9 (c 2.0, CHCl3); dH (400 MHz, CDCl3) 1.53 (18H, s,
2tBu), 2.86 (1H, ddd, J 18.0, 6.0, 1.2 Hz, 3-HH), 3.45 (1H, ddd, J 18.0,
6.8, 1.2 Hz, 3-HH), 3.76 (3H, s, OMe), 5.57 (1H, dd, J 6.8, 6.0 Hz, 2-H),
9.82 (1H, br t, J 1.2 Hz, 4-H); dC (101 MHz, CDCl3) 27.9 (6CH3), 45.0
(CH2), 52.6 (CH3), 52.9 (CH), 83.7 (2C), 151.7 (2C), 170.2 (C), 198.4
(C); m/z (CI) 332 (MHþ, 8%), 276 (60), 236 (51), 220 (100), 192 (98),
176 (86), 132 (26); HRMS (CI): MHþ, found 332.1708. C15H26NO7
requires 332.1709.4.5. Methyl (2S)-2-(di-tert-butoxycarbonylamino)-4-oxo-5-
(trimethylsilanyl)pentanoate (9)
Methyl (2S)-2-(di-tert-butoxycarbonylamino)-4-oxobutanoate
(8) (0.10 g, 0.30 mmol) was added to a solution of trimethylalu-
minium (0.20 mL, 0.40 mmol) in dichloromethane (10 mL) at
78 C. Trimethylsilyldiazomethane (0.20 mL, 0.30 mmol) was
added and the reactionmixture stirred at78 C for 1 h and then at
40 C for 1 h. The solution was then poured into 0.1 M hydro-
chloric acid (10 mL) and extracted using dichloromethane
(315 mL). The organic layers were combined, dried (MgSO4) and
concentrated in vacuo. Puriﬁcation by ﬂash chromatography (20%
ethyl acetate in petroleum ether) gave methyl (2S)-2-(di-tert-
butoxycarbonylamino)-4-oxo-5-(trimethylsilanyl)pentanoate (9)
as a pale yellow oil (0.09 g, 71%). nmax (NaCl) 2980 (CH),1795 (C]O),
1747 (C]O), 1144, 853 cm1; [a]D25 72.5 (c 0.4, CHCl3); dH
(400 MHz, CDCl3) 0.01 (9H, s, SiMe3), 1.56 (18H, s, 2tBu), 2.08 (1H,
d, J 10.4 Hz, 5-HH), 2.13 (1H, d, J 10.4 Hz, 5-HH), 2.62 (1H, dd, J 18.0,
5.6 Hz, 3-HH), 3.22 (1H, dd, J 18.0, 6.8 Hz, 3-HH), 3.56 (3H, s, OMe),
5.35e5.40 (1H, m, 2-H); dC (101 MHz, CDCl3) 0.0 (3CH3), 29.1
(6CH3), 39.3 (CH2), 46.7 (CH2), 53.5 (CH), 55.2 (CH3), 84.4 (2C),
152.9 (2C), 172.0 (C), 206.2 (C); m/z (CI) 418 (MHþ, 16%), 346 (53),
318 (78), 262 (95), 234 (99), 218 (25), 190 (100), 146 (89); HRMS
(CI): MHþ, found 418.2262. C19H36NO7Si requires 418.2261.4.6. Methyl (2S)-2-(di-tert-butoxycarbonylamino)-4-oxo-5-
(trimethylsilanyl)pentanoate (9)
Methyl (2S)-2-(di-tert-butoxycarbonylamino)-4-oxobutanoate
(8) (0.10 g, 0.30 mmol) was dissolved in dichloromethane
(10 mL). Tin(II) chloride (0.003 g, 0.015 mmol) and trimethylsi-
lyldiazomethane (0.15mL, 0.30mmol) were added and the solution
was allowed to stir at room temperature for 0.5 h. The reaction was
quenched with 0.1 M hydrochloric acid (10 mL) and extracted with
dichloromethane (20 mL). The organic layers were combined,
washed with brine (20 mL), dried (MgSO4) and concentrated in
vacuo. Puriﬁcation by ﬂash chromatography (20% ethyl acetate in
petroleum ether) gave methyl (2S)-2-(di-tert-butoxycarbonyl
amino)-4-oxo-5-(trimethylsilanyl)pentanoate (9) as a pale yellow
oil (0.09 g, 85%). Spectroscopic data as reported above.
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(10)17
Lithium bromide (2.33 g, 26.8 mmol) was added to a stirring
solution of methyl (2S)-2-(di-tert-butoxycarbonylamino)-4-
oxobutanoate (8) (2.90 g, 8.75 mmol) in acetonitrile (100 mL).
The mixture was then heated at 65 C for 14 h before being con-
centrated under reduced pressure. Puriﬁcation by ﬂash chroma-
tography (30% ethyl acetate in hexane) gave methyl (2S)-2-(tert-
butoxycarbonylamino)-4-oxobutanoate (10) as a colourless oil
(1.86 g, 92%). [a]Dþ20.4 (c 1.0, CHCl3), lit.17 [a]Dþ16.4 (c 5.0, CHCl3);
dH (400 MHz, CDCl3) 1.38 (9H, s, tBu), 2.95 (1H, dd, J 18.4, 4.6 Hz, 3-
HH), 3.05 (1H, dd, J 18.4, 5.0 Hz, 3-HH), 3.69 (3H, s, OMe), 4.51e4.56
(1H, m, 2-H), 5.33 (1H, br d, J 7.6 Hz, NH), 9.67 (1H, br s, 4-H); dC
(101 MHz, CDCl3) 27.3 (3CH3), 45.0 (CH2), 47.5 (CH), 51.8 (CH3),
79.3 (C), 154.4 (C), 170.5 (C), 198.4 (C);m/z (CI) 232 (MHþ, 45%), 176
(100), 132 (79); HRMS (CI): MHþ, found 232.1181. C10H18NO5 re-
quires 232.1185.
4.8. Methyl (2S)-2-(tert-butoxycarbonylamino)-4-oxo-5-(tri-
methylsilanyl)pentanoate (11)
Tin(II) chloride (0.004 g, 0.021 mmol) was dried in an oven at
110 C overnight and then under vacuum at 100 C for 3 h in
a round bottomed ﬂask equipped with a stirrer bar. After the ﬂask
was cooled to room temperature and ﬂushed with argon, a 2.0 M
solution of trimethylsilyldiazomethane in diethyl ether (0.22 mL,
0.43 mmol) was added. A solution of methyl (2S)-2-(tert-butox-
ycarbonylamino)-4-oxobutanoate (10) (0.10 g, 0.43 mmol) in
dichloromethane (4 mL) was then added dropwise with stirring.
The mixture was stirred at room temperature for 1 h before water
(5 mL) was added. The reaction was quenched with 0.1 M hydro-
chloric acid (3 mL) and extracted with diethyl ether (310 mL). The
organic layers were combined, dried (MgSO4) and concentrated in
vacuo. Puriﬁcation by ﬂash chromatography (30% ethyl acetate in
petroleum ether) gave methyl (2S)-2-(tert-butoxycarbonylamino)-
4-oxo-5-(trimethylsilanyl)pentanoate (11) as a pale yellow oil
(0.12 g, 88%). nmax (NaCl) 3370 (NH), 2955 (CH), 1716 (C]O), 1499,
1253, 1168, 854 cm1; [a]D26 þ31.6 (c 1.0, CHCl3); dH (400 MHz,
CDCl3) 0.00 (9H, s, SiMe3), 1.31 (9H, s, tBu), 2.08 (2H, s, 5-H2), 2.79
(1H, dd, J 18.4, 4.0 Hz, 3-HH), 3.02 (1H, dd, J 18.4, 4.0 Hz, 3-HH), 3.60
(3H, s, OMe), 4.28e4.31 (1H, m, 2-H), 5.43 (1H, d, J 8.4 Hz, NH); dC
(101 MHz, CDCl3) 0.0 (3CH3), 29.5 (3CH3), 39.2 (CH2), 47.2 (CH2),
50.7 (CH), 53.7 (CH3), 81.0 (C), 156.7 (C), 173.2 (C), 208.4 (C);m/z (CI)
318 (MHþ, 12%), 279 (31), 262 (100), 218 (46), 207 (71), 146 (21);
HRMS (CI): MHþ, found 318.1740. C14H28NO5Si requires 318.1737.
4.9. Methyl (2S)-2-(tert-butoxycarbonylamino)-4-
oxopentanoate (12)24
Methyl (2S)-2-(tert-butoxycarbonylamino)-4-oxo-5-(trime-
thylsilanyl)pentanoate (11) (0.10 g, 0.30 mmol) was dissolved in
a 5% solution of potassium hydroxide in methanol (10 mL). This
mixture was allowed to stir at room temperature for 1 h. The sol-
vent was then removed under vacuum. The residue was dissolved
in ethyl acetate (20 mL), dried (MgSO4) and concentrated in vacuo.
Puriﬁcation by ﬂash chromatography (50% ethyl acetate in petro-
leum ether) gave methyl (2S)-2-(tert-butoxycarbonylamino)-4-
oxopentanoate (12) as a pale yellow oil (0.067 g, 92%). [a]D25 þ30.8
(c 2.1, CHCl3), lit.24 [a]D22 þ32.7 (c 1.0, CHCl3); nmax (neat) 3420 (NH),
3082 (CH), 1774 (C]O), 1612, 1466, 1111, 945 cm1; dH (400 MHz,
CDCl3) 1.47 (9H, s, tBu), 2.20 (3H, s, 5-H3), 2.98 (1H, dd, J 18.4, 4.2 Hz,
3-HH), 3.22 (1H, dd, J 18.4, 4.4 Hz, 3-HH), 3.76 (3H, s, OMe),
4.49e4.54 (1H, m, 2-H), 5.53 (1H, br d, J 8.4 Hz, NH); dC (101 MHz,
CDCl3) 28.3 (CH3), 29.9 (3CH3), 45.4 (CH2), 49.4 (CH), 52.7 (CH3),
80.1 (C), 155.6 (C), 171.9 (C), 206.7 (C); m/z (FAB) 246 (MHþ, 45%),190 (100), 147 (67), 89 (23); HRMS (FAB): MHþ, found 246.1343.
C11H20NO5 requires 246.1341.
4.10. (2S)-2-(tert-Butoxycarbonylamino)-4-oxopentanoic acid
(13)20f
Methyl (2S)-2-(tert-butoxycarbonylamino)-4-oxopentanoate
(12) (0.20 g, 0.70 mmol) was dissolved in a 1:1 mixture of metha-
nol and water (20 mL). Caesium carbonate (0.30 g, 0.90 mmol) was
added and the reaction mixture stirred at room temperature for
24 h. The mixture was acidiﬁed with 1 M hydrochloric acid (10 mL)
and extracted with dichloromethane (310 mL). The organic layers
were combined, dried (MgSO4) and concentrated in vacuo to give
(2S)-2-(tert-butoxycarbonylamino)-4-oxopentanoic acid (13) as
a viscous colourless oil (0.15 g, 94%). Spectroscopic data were
consistent with the literature.20f nmax (neat) 3357 (NH), 3030 (CH),
1743 (C]O), 1688, 1456, 1138 cm1; [a]D27 þ26.1 (c 0.3, CHCl3); dH
(400 MHz, CDCl3) 1.38 (9H, s, tBu), 2.13 (3H, s, 5-H3), 2.88 (1H, dd, J
18.2, 4.8 Hz, 3-HH), 3.14 (1H, dd, J 18.2, 3.6 Hz, 3-HH), 4.46 (1H, ddd,
J 8.4, 4.8, 3.6 Hz, 2-H), 5.48 (1H, br d, J 8.4 Hz, NH); dC (101 MHz,
CDCl3) 28.3 (3CH3), 30.0 (CH3), 45.1 (CH2), 49.3 (CH), 80.5 (C),
155.8 (C),175.1 (C), 207.3 (C);m/z (CI) 232 (MHþ, 18%),176 (100),158
(33), 132 (95), 130 (36), 73 (40); HRMS (CI): MHþ, found 232.1189.
C10H18NO5 requires 232.1185.
4.11. Methyl (2S,5E)-2-(tert-butoxycarbonylamino)-4-oxo-6-
phenylhex-5-enoate (14)21f
To a solution of diisopropylamine (0.12 mL, 0.84 mmol) in tet-
rahydrofuran (4 mL) at 78 C was added dropwise, a solution of
2.5 M n-butyllithium in hexane (0.33 mL, 0.84 mmol). The mixture
was stirred for 0.15 h before being added by cannula to a solution of
methyl (2S)-2-(tert-butoxycarbonylamino)-4-oxo-5-(trimethylsi-
lanyl)pentanoate (11) (0.12 g, 0.38mmol) in tetrahydrofuran (5mL).
After 1 h, benzaldehyde (0.04 mL, 0.38 mmol) in tetrahydrofuran
(3mL) was added and the reactionmixture stirred for 5 h at78 C.
The reaction was quenched by addition of a saturated solution of
ammonium chloride (2.0mL) and themixturewaswarmed to room
temperature. The solutionwas extractedwith ethyl acetate (40mL),
washed with brine (20 mL), dried (MgSO4) and concentrated in
vacuo. Puriﬁcation by ﬂash chromatography (10% ethyl acetate in
petroleum ether) gave methyl (2S,5E)-2-(tert-butoxycarbonyl
amino)-4-oxo-6-phenylhex-5-enoate (14) a colourless oil (0.061 g,
48%). nmax (NaCl) 3368 (NH), 2979 (CH), 1747 (C]O), 1713 (C]O),
1663 (C]C), 1496, 1367, 1168 cm1; [a]D17 þ56.9 (c 1.0, CHCl3); dH
(400MHz, CDCl3) 1.44 (9H, s, tBu), 3.33 (1H, dd, J 17.8, 4.3 Hz, 3-HH),
3.44 (1H, dd, J 17.8, 4.1 Hz, 3-HH), 3.75 (3H, s, OMe), 4.62 (1H, ddd, J
8.5, 4.3, 4.1 Hz, 2-H), 5.60 (1H, d, J 8.5 Hz, NH), 6.71 (1H, d, J 16.1 Hz,
5-H), 7.38e7.42 (3H, m, ArH), 7.52e7.55 (2H, m, ArH), 7.57 (1H, d, J
16.1 Hz, 6-H); dC (101 MHz, CDCl3) 28.3 (3CH3), 42.4 (CH2), 49.6
(CH), 52.6 (CH3), 79.9 (C), 125.6 (CH), 128.4 (2CH), 129.2 (2CH),
130.9 (CH), 134.1 (C), 143.9 (CH), 155.6 (C), 172.0 (C), 197.6 (C); m/z
(CI) 334 (MHþ, 9%), 320 (4), 278 (100), 234 (13); HRMS (CI): MHþ,
found 334.1653. C18H24NO5 requires 334.1654.
4.12. Methyl (2S,5E)-2-(tert-butoxycarbonylamino)-6-(40-bro-
mophenyl)-4-oxohex-5-enoate (15)21f
The reaction was performed as described above, using (2S)-2-
(tert-butoxycarbonylamino)-4-oxo-5-(trimethylsilanyl)pentanoate
(11) (0.80 g, 2.52 mmol) and 4-bromobenzaldehyde (0.56 g,
3.0 mmol). Puriﬁcation by ﬂash chromatography (20% ethyl acetate
in petroleum ether) gave methyl (2S,5E)-2-(tert-butoxycarbonyl
amino)-6-(40-bromophenyl)-4-oxohex-5-enoate (15) as a white
solid (0.48 g, 46%). Mp 78e79 C; nmax (NaCl) 3437 (NH), 3370, 2978
(CH), 1747 (C]O), 1712 (C]O), 1666 (C]C), 1611, 1488, 1168 cm1;
C.M. Reid et al. / Tetrahedron 71 (2015) 245e251250[a]D20þ42.4 (c 1.0, CHCl3); dH (400MHz, CDCl3) 1.44 (9H, s, tBu), 3.22
(1H, d, J 17.8 Hz, 3-HH), 3.41 (1H, d, J 17.8 Hz, 3-HH), 3.75 (3H, s,
OMe), 4.58e4.64 (1H, m, 2-H), 5.56 (1H, d, J 8.0 Hz, NH), 6.69 (1H, d,
J 16.0 Hz, 5-H), 7.40 (2H, d, J 8.0 Hz, ArH), 7.46e7.56 (3H, m, 6-H and
ArH); dC (101 MHz, CDCl3) 28.3 (3CH3), 42.6 (CH2), 49.6 (CH), 52.7
(CH3), 80.0 (C), 125.2 (C), 126.0 (CH), 129.8 (2CH), 132.3 (2CH),
133.0 (C), 142.5 (CH), 155.6 (C), 172.0 (C), 197.5 (C); m/z (FAB) 412
(MHþ, 22%), 358 (100), 356 (89), 314 (23), 278 (22), 234 (7); HRMS
(FAB): MHþ, found 412.0755. C18H2379BrNO5 requires 412.0760.
4.13. Methyl (2S,5E)-2-(tert-butoxycarbonylamino)-4-oxo-8-
phenyloct-5-enoate (16)21f
The reaction was performed as described above, using (2S)-2-
(tert-butoxycarbonylamino)-4-oxo-5-(trimethylsilanyl)pentanoate
(11) (0.80 g, 2.52 mmol) and 3-phenylpropionaldehyde (0.40 g,
3.0 mmol). Puriﬁcation by ﬂash chromatography (15% ethyl acetate
in petroleum ether) gave methyl (2S,5E)-2-(tert-butox-
ycarbonylamino)-4-oxo-8-phenyloct-5-enoate (16) as a colourless
oil (0.46 g, 53%). nmax (NaCl) 3439 (NH), 3371, 3027, 3004, 2978
(CH), 2952, 2930, 2859, 1749 (C]O), 1714 (C]O), 1672, 1630, 1584
(C]C), 1497, 1367, 1167 cm1; [a]D19 þ47.4 (c 1.0, CHCl3); dH
(400 MHz, CDCl3) 1.44 (9H, s, tBu), 2.46e2.63 (2H, m, 7-H2), 2.79
(2H, t, J 7.7 Hz, 8-H2), 3.06 (1H, dd, J 18.0, 4.0 Hz, 3-HH), 3.30 (1H, dd,
J 18.0, 4.0 Hz, 3-HH), 3.73 (3H, s, OMe), 4.42e4.64 (1H, m, 2-H), 5.53
(1H, br d, J 8.8 Hz, NH), 6.10 (1H, dt, J 16.0,1.4 Hz, 5-H), 6.88 (1H, dt, J
16.0, 6.8 Hz, 6-H), 7.11e7.37 (5H, m, ArH); dC (101 MHz, CDCl3) 28.3
(CH3), 34.2 (CH2), 34.3 (CH2), 41.8 (CH2), 49.5 (CH), 52.6 (CH3), 79.9
(C), 126.3 (CH), 128.3 (2CH), 128.6 (2CH), 130.3 (CH), 140.5 (C),
147.8 (CH), 155.6 (C), 172.0 (C), 197.7 (C); m/z (FAB) 362 (MHþ, 14%),
306 (94), 262 (100), 203 (11), 176 (14), 160 (34), 93 (35), 90 (32);
HRMS (FAB): MHþ, found 362.1974. C20H28NO5 requires 362.1967.
4.14. (2S,5E)-2-Amino-4-oxo-6-phenylhex-5-enoic acid hy-
drochloride (17)
To a solution of methyl (2S,5E)-2-(tert-butoxycarbonylamino)-
4-oxo-6-phenylhex-5-enoate (14) (0.20 g, 0.60 mmol) in methanol
(3.0 mL) was added 6.0 M hydrochloric acid (15 mL) and the re-
action mixture heated under reﬂux for 24 h. The mixture was
allowed to cool to room temperature and then extracted with
diethyl ether (220 mL). The aqueous layer was concentrated in
vacuo to give a yellow solid. Recrystallisation from chloroform and
methanol gave (2S,5E)-2-amino-4-oxo-6-phenylhex-5-enoic acid
hydrochloride (17) as an off-white solid (0.095 g, 62%). Mp
151e153 C (decomposition); nmax (neat) 3058 (NH), 2976 (CH),
1736 (C]O), 1649 (C]C), 1174, 1126, 854 cm1; [a]D24 þ35.8 (c 1.0,
MeOH); dH (400 MHz, CD3OD) 3.38e3.58 (2H, m, 3-H2), 4.36 (1H,
dd, J 6.6, 4.2 Hz, 2-H), 6.92 (1H, d, J 16.3 Hz, 5-H), 7.38e7.50 (3H, m,
ArH), 7.63e7.71 (2H, m, ArH), 7.76 (1H, d, J 16.3 Hz, 6-H); dC
(101 MHz, CD3OD) 40.7 (CH2), 49.3 (CH), 126.0 (CH), 129.8 (2CH),
130.2 (2CH), 132.2 (CH), 135.6 (C), 146.2 (CH), 171.3 (C), 197.6 (C);
m/z (CI) 220 (MHþ, 84%), 205 (100), 203 (61), 159 (53), 147 (34), 113
(21), 97 (20), 81 (50), 69 (61); HRMS (CI): MHþ, found 220.0978.
C12H14NO3 requires 220.0974.
4.15. General procedure for the deprotection of enones 14, 15
and 16
To a solution of N-Boc-protected amino methyl ester
(0.16 mmol) in 1:1 methanol/water (4 mL) was added caesium
carbonate (0.21 mmol). The resultant suspension was stirred at
room temperature for 48 h. The reaction mixture was concentrated
in vacuo and the residue was dissolved in water (10 mL) and
acidiﬁed to pH 1 with hydrochloric acid (1 M). The aqueous layer
was washed with dichloromethane (320 mL) and the combinedorganic layers were concentrated in vacuo. To a solution of the
resulting residue (0.16 mmol) in dichloromethane (2 mL) was
added triﬂuoroacetic acid (0.80 mmol) and the reaction mixture
was stirred at room temperature under argon for 3 h. The reaction
mixture was concentrated in vacuo to give the TFA salts, which
were puriﬁed by recrystallisation from chloroform and methanol.
4.15.1. (2S,5E)-2-Amino-4-oxo-6-phenylhex-5-enoic acid tri-
ﬂuoroacetate (18).21f Using the general procedure above gave
(2S,5E)-2-amino-4-oxo-6-phenylhex-5-enoic acid triﬂuoroacetate
(18) as a white solid (0.13 g, 95%). Mp 112e114 C (decomposition);
nmax (neat) 3028 (NH), 2914 (CH), 1738 (C]O), 1655 (C]C), 1495,
1184, 1134 cm1; [a]D19 þ23.3 (c 1.0, MeOH); dH (400 MHz, CD3OD)
3.43 (1H, dd, J 18.5, 6.1 Hz, 3-HH), 3.48e3.56 (1H, m, 3-HH),
4.22e4.28 (1H, m, 2-H), 6.92 (1H, d, J 16.2 Hz, 5-H), 7.40e7.48 (3H,
m, ArH), 7.62e7.69 (2H, m, ArH), 7.74 (1H, d, J 16.2 Hz, 6-H); dC
(101 MHz, CD3OD) 40.9 (CH2), 50.2 (CH), 126.1 (CH), 129.7 (2CH),
130.2 (2CH), 132.1 (CH), 135.6 (C), 146.0 (CH), 171.8 (C), 198.0 (C);
m/z (FAB) 220 (MHþ, 42%), 175 (7), 148 (16), 132 (12); HRMS (FAB):
MHþ, found 220.0973. C12H14NO3 requires 220.0974.
4.15.2. (2S,5E)-2-Amino-6-(40-bromophenyl)-4-oxohex-5-enoic acid
triﬂuoroacetate (19).21f Using the general procedure above gave
(2S,5E)-2-amino-6-(40-bromophenyl)-4-oxohex-5-enoic acid tri-
ﬂuoroacetate (19) as a white solid (0.14 g, 93%). Mp 151e152 C
(decomposition); nmax (neat) 3364 (NH), 3061, 1684 (C]O), 1607
(C]C), 1547, 1487, 1397, 1339 cm1; [a]D18 þ55.0 (c 0.3, MeOH); dH
(400 MHz, CD3OD) 3.23 (1H, dd, J 18.8, 9.3 Hz, 3-HH), 3.46 (1H, dd, J
18.8, 3.4 Hz, 3-HH), 3.95 (1H, dd, J 9.3, 3.4 Hz, 2-H), 6.91 (1H, d, J
16.3 Hz, 5-H), 7.56e7.62 (4H, m, ArH), 7.67 (1H, d, J 16.3 Hz, 6-H); dC
(101 MHz, CD3OD) 40.9 (CH2), 50.2 (CH), 126.2 (C), 126.7 (CH), 131.3
(2CH), 133.4 (2CH), 134.8 (C), 144.6 (CH), 171.5 (C), 197.7 (C);m/z
(FAB) 298 (MHþ, 31%), 292 (16), 254 (12), 243 (21), 209 (18), 155
(29), 138 (15); HRMS (FAB): MHþ, found 298.0067. C12H1379BrNO3
requires 298.0079.
4.15.3. (2S,5E)-2-Amino-4-oxo-8-phenyloct-5-enoic acid tri-
ﬂuoroacetate (20).21f The general two-step procedure described
above was used except that a 1:1 acetonitrile/water solution was
used for the hydrolysis step. This gave (2S,5E)-2-amino-4-oxo-8-
phenyloct-5-enoic acid triﬂuoroacetate (20) as a white solid
(0.10 g, 98%). Mp 94e96 C (decomposition); nmax (neat) 3161 (NH),
3030, 2918 (CH), 1736 (C]O), 1661 (C]C), 1640, 1604, 1497,
1180 cm1; [a]D18 þ10.2 (c 0.3, MeOH); dH (400 MHz, CD3OD)
2.54e2.63 (2H, m, 7-H2), 2.82 (2H, t, J 7.4 Hz, 8-H2), 3.20 (1H, dd, J
18.8, 8.0 Hz, 3-HH), 3.28e3.37 (1H, m, 3-HH), 4.11 (1H, dd, J 8.0,
3.6 Hz, 2-H), 6.17 (1H, dt, J 16.0, 1.4 Hz, 5-H), 7.03 (1H, dt, J 16.0,
6.9 Hz, 6-H), 7.12e7.31 (5H, m, ArH); dC (101 MHz, CD3OD) 35.3
(CH2), 35.5 (CH2), 40.4 (CH2), 50.5 (CH), 127.3 (CH), 129.5 (2CH),
129.6 (2CH), 130.8 (CH), 142.1 (C), 150.5 (CH), 172.5 (C), 198.1 (C);
m/z (FAB) 248 (MHþ, 14%), 247 (2), 203 (8), 176 (12), 160 (8), 132 (4),
100 (1), 90 (3), 76 (4); HRMS (FAB): MHþ, found 248.1289.
C14H18NO3 requires 248.1287.Acknowledgements
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